Clinical trial
Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly…
NCT00454662 · COLM Study Research Organization, Other · Completed
Key facts
| NCT number | NCT00454662 |
|---|---|
| Title | Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study) |
| Official title | Combination of OLMesartan and Calcium Channel Blocker or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study) |
| Lead sponsor | COLM Study Research Organization, Other |
| Collaborators | Japan Heart Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Cardiovascular Disease, Diabetes |
| Intervention type | Drug |
| Interventions | olmesartan medoxomil / amlodipine or azelnidipine, olmesartan medoxomil / low dose thiazide type drug |
| Enrollment | 5,141 |
| Start date | Apr 1, 2007 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Apr 2, 2007 |
| Last update posted | Jan 23, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: